Adam Janik

1.1k total citations
9 papers, 286 citations indexed

About

Adam Janik is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Adam Janik has authored 9 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Psychiatry and Mental health and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Adam Janik's work include Treatment of Major Depression (3 papers), Schizophrenia research and treatment (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Adam Janik is often cited by papers focused on Treatment of Major Depression (3 papers), Schizophrenia research and treatment (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Adam Janik collaborates with scholars based in United States, Belgium and France. Adam Janik's co-authors include Alain Schotte, Adam Savitz, Haiyan Xu, David Hough, Srihari Gopal, Isaac Nuamah, Paulien Ravenstijn, Wolfgang Fleischhacker, Kaire Aadamsoo and Mathias Zink and has published in prestigious journals such as Schizophrenia Research, JAMA Psychiatry and The International Journal of Neuropsychopharmacology.

In The Last Decade

Adam Janik

8 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Janik United States	5	229	79	63	61	35	9	286
Jennifer Kern Sliwa United States	12	334 1.5×	69 0.9×	74 1.2×	66 1.1×	56 1.6×	19	419
Fuminari Misawa Japan	9	431 1.9×	90 1.1×	93 1.5×	93 1.5×	29 0.8×	28	488
Danielle Coppola United States	9	263 1.1×	49 0.6×	56 0.9×	44 0.7×	80 2.3×	13	370
Yanning Liu United States	5	358 1.6×	88 1.1×	73 1.2×	56 0.9×	73 2.1×	8	389
Charmi Patel United States	10	255 1.1×	80 1.0×	54 0.9×	36 0.6×	25 0.7×	32	303
C.U. Correll United States	5	312 1.4×	77 1.0×	81 1.3×	58 1.0×	24 0.7×	17	377
L. Hargarter Germany	12	453 2.0×	147 1.9×	151 2.4×	52 0.9×	38 1.1×	33	497
Kensuke Nomura Japan	9	236 1.0×	59 0.7×	58 0.9×	52 0.9×	22 0.6×	11	300
N. Maruta Ukraine	4	151 0.7×	40 0.5×	43 0.7×	24 0.4×	44 1.3×	33	186
Dean Najarian United States	8	243 1.1×	24 0.3×	32 0.5×	42 0.7×	37 1.1×	14	315

Countries citing papers authored by Adam Janik

Since Specialization

Citations

This map shows the geographic impact of Adam Janik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Janik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Janik more than expected).

Fields of papers citing papers by Adam Janik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Janik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Janik. The network helps show where Adam Janik may publish in the future.

Co-authorship network of co-authors of Adam Janik

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Janik. A scholar is included among the top collaborators of Adam Janik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Janik. Adam Janik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Janik, Adam, Xin Qiu, Rosanne Lane, et al.. (2025). Esketamine Monotherapy in Adults With Treatment-Resistant Depression. JAMA Psychiatry. 82(9). 877–877. 4 indexed citations

Janik, Adam, et al.. (2024). Efficacy and safety of esketamine nasal spray as monotherapy in adults with treatment-resistant depression: a randomized, double-blind, placebo-controlled study. Neuroscience Applied. 3. 105279–105279. 1 indexed citations

Iungo, Giacomo Valerio, D. Todd Griffith, Mario A. Rotea, et al.. (2022). Wind-tunnel Force-measurements of Gurney Flaps for Active Control of Wind Turbine Blades. AIAA SCITECH 2022 Forum. 1 indexed citations

Doty, Richard L., Vanina Popova, Maggie Fedgchin, et al.. (2021). Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies. CNS Drugs. 35(7). 781–794. 14 indexed citations

Wajs, Ewa, Leah Aluisio, Ibrahim Turkoz, et al.. (2020). Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data. The International Journal of Neuropsychopharmacology. 23(7). 426–433. 15 indexed citations

Wajs, Ewa, et al.. (2019). P.033 Managing esketamine treatment frequency toward successful outcomes: Analysis of phase 3 data. European Neuropsychopharmacology. 29. S43–S44.

Savitz, Adam, Haiyan Xu, Srihari Gopal, et al.. (2016). Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study. The International Journal of Neuropsychopharmacology. 19(7). pyw018–pyw018. 128 indexed citations

Schreiner, A., Kaire Aadamsoo, A.C. Altamura, et al.. (2015). Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia. Schizophrenia Research. 169(1-3). 393–399. 115 indexed citations

Janik, Adam, et al.. (2013). Radiotherapy for Stage III Non–Small-Cell Lung Carcinoma in the Elderly (Age ≥ 70 years). Clinical Lung Cancer. 14(6). 674–679. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact